The tiny jellyfish Turritopsis dohrnii has amazed scientists with its rare ability to revert to an earlier stage of its life cycle, effectively sidestepping ageing and earning the nickname “the ...
Much of the GI community has anchored its view of AI to adenoma detection rates, but Neil Parikh, MD, a gastroenterologist with Farmington-based Connecticut GI, says the bigger disruption will come ...
Discovering what structure, material and colour is the most attractive for picky coral larvae could help bolster reef ...
Metabolic syndrome and its components, including obesity and hypertension, significantly increase the risk for precancerous polyp recurrence.
Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and ...
Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitisApproval in adults and ...
Dupixent (dupilumab) is now FDA-approved for adults and children aged 6 years and older with allergic fungal rhinosinusitis and prior sino-nasal surgery.
LIBERTY-AFRS-AIMS met its primary endpoint with a 50% reduction in CT sinus opacification at week 52 versus 10% with placebo (P<.0001).
Medtronic (NYSE: MDT) announced today that it received CE mark for its ColonPRO fourth-generation software for AI-assisted colonoscopy.
The risk for colon cancer is rising in young people, as James Van Der Beek dies from the disease at 48.
You can reduce your risk of developing bowel cancer just by adopting a healthier lifestyle. Some helpful changes you can make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results